Roger Lassing
Corporate Officer/Principal bei ICONOVO AB
Profil
Roger Lassing is currently the Vice President of Business Development at Iconovo AB.
Previously, he held positions as Vice President at Takeda Pharmaceutical Co., Ltd., Vice President & Global Brand Manager at AstraZeneca AB, and Senior Manager of Global Business Development at LEO Pharma AB.
Lassing received his undergraduate degree and MBA from the University of Lund.
Aktive Positionen von Roger Lassing
| Unternehmen | Position | Beginn |
|---|---|---|
| ICONOVO AB | Corporate Officer/Principal | 01.01.2019 |
Ehemalige bekannte Positionen von Roger Lassing
| Unternehmen | Position | Ende |
|---|---|---|
| LEO Pharma AB | Corporate Officer/Principal | - |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Corporate Officer/Principal | - |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Corporate Officer/Principal | - |
Ausbildung von Roger Lassing
| University of Lund | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ICONOVO AB | Health Technology |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Health Technology |
| Private Unternehmen | 2 |
|---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
| LEO Pharma AB |
